SE0301905D0 - Novel imidazopyridine compound I with therapeutic effect - Google Patents

Novel imidazopyridine compound I with therapeutic effect

Info

Publication number
SE0301905D0
SE0301905D0 SE0301905A SE0301905A SE0301905D0 SE 0301905 D0 SE0301905 D0 SE 0301905D0 SE 0301905 A SE0301905 A SE 0301905A SE 0301905 A SE0301905 A SE 0301905A SE 0301905 D0 SE0301905 D0 SE 0301905D0
Authority
SE
Sweden
Prior art keywords
therapeutic effect
imidazopyridine compound
novel imidazopyridine
gastric acid
novel
Prior art date
Application number
SE0301905A
Other languages
Swedish (sv)
Inventor
Peter Nordberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0301905A priority Critical patent/SE0301905D0/en
Publication of SE0301905D0 publication Critical patent/SE0301905D0/en
Priority to TW093117963A priority patent/TW200508234A/en
Priority to ARP040102164A priority patent/AR044853A1/en
Priority to PCT/SE2004/001012 priority patent/WO2004113338A1/en
Priority to UY28385A priority patent/UY28385A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention relates to imidazo pyridine derivatives of the Formula I which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastric acid related diseases or gastrointestinal inflammatory diseases.
SE0301905A 2003-06-26 2003-06-26 Novel imidazopyridine compound I with therapeutic effect SE0301905D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0301905A SE0301905D0 (en) 2003-06-26 2003-06-26 Novel imidazopyridine compound I with therapeutic effect
TW093117963A TW200508234A (en) 2003-06-26 2004-06-21 Novel imidazopyridine compound I with therapeutic effect
ARP040102164A AR044853A1 (en) 2003-06-26 2004-06-22 IMIDAZOPIRIDINE COMPOUND
PCT/SE2004/001012 WO2004113338A1 (en) 2003-06-26 2004-06-23 Novel imidazopyridine compound i with therapeutic effect
UY28385A UY28385A1 (en) 2003-06-26 2004-06-24 NEW IMIDAZOPIRIDINE I COMPOUND WITH THERAPEUTIC EFFECT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301905A SE0301905D0 (en) 2003-06-26 2003-06-26 Novel imidazopyridine compound I with therapeutic effect

Publications (1)

Publication Number Publication Date
SE0301905D0 true SE0301905D0 (en) 2003-06-26

Family

ID=27656638

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301905A SE0301905D0 (en) 2003-06-26 2003-06-26 Novel imidazopyridine compound I with therapeutic effect

Country Status (5)

Country Link
AR (1) AR044853A1 (en)
SE (1) SE0301905D0 (en)
TW (1) TW200508234A (en)
UY (1) UY28385A1 (en)
WO (1) WO2004113338A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1934215A1 (en) * 2005-09-22 2008-06-25 Nycomed GmbH Isotopically substituted imidazopyridine derivatives for the treatment of gastrointestinal disorders
FI20086158A0 (en) * 2008-12-03 2008-12-03 Mikael Dahlstroem imidazopyridine
EP2452680B1 (en) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (en) * 1998-04-29 1998-04-29 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2004113338A1 (en) 2004-12-29
AR044853A1 (en) 2005-10-05
UY28385A1 (en) 2005-01-31
TW200508234A (en) 2005-03-01

Similar Documents

Publication Publication Date Title
MX2011005769A (en) Imidazopyridine derivatives which inhibit the secretion of gastric acid.
SE9801526D0 (en) New compounds
NO20082594L (en) Pyrimidinylbenzotiofenforbindelser
SE9700661D0 (en) New compounds
SE9704404D0 (en) New compounds
NO20064732L (en) Alpha-aminoamide derivatives are useful in the treatment of troubled bone syndrome and additive disorders
NO20064120L (en) 3,4-heterocyclyl-1,2,3-triazol-1-yl-N-aryl-benzamide are inhibitors of cytokine production for the treatment of chronic inflammatory diseases
ATE457313T1 (en) BICYCLIC HETEROCYCLIC P-38 KINASE INHIBITORS
ECSP055844A (en) NEW TRICYCLE COMPOUNDS
MXPA04001402A (en) Novel imidazopyridine compounds with therapeutic effect.
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
SE9401197D0 (en) Active compounds
SE9802794D0 (en) New compounds
SE9602286D0 (en) New compounds
NO20064632L (en) Tricyclic imidazopyridines
SE9802793D0 (en) New compounds
NO20063220L (en) Tricyclic imidazopyridines for use as gastric secretion inhibitors
SE0301905D0 (en) Novel imidazopyridine compound I with therapeutic effect
NO20060425L (en) New imidazopyridine compound II with therapeutic effect
SE0301903D0 (en) Novel imidazopyridine compound III with therapeutic effect
NO20065200L (en) Dialkoxy imidazopyridine
AR044854A1 (en) IMIDAZOPIRIDINE COMPOUND
ES2150494T3 (en) SUBSTITUTED DERIVATIVES OF QUINOLINE AND ITS USE AS INHIBITORS OF THE GASTRIC ACID SECRETION.
NO20070058L (en) Amino-halo-imidazopyridines as proton pump inhibitors
NO20072340L (en) Difluoro-substituted imidazopyridines